LONDON, April 28, 2025 (GLOBE NEWSWIRE) -- Spur Therapeutics today announced that it will share new data from its gene ... in oral and poster presentations at the American Society of Gene and ...

LONDON, April 28, 2025 (GLOBE NEWSWIRE) -- Spur Therapeutics today announced that it will share new data from its gene therapy programs in Gaucher disease, GBA1 Parkinson's disease and ...

today announced that data on the long term efficacy and safety of its ALXN1840 (tiomolybdate choline) drug candidate for Wilson disease has been accepted for a late-breaker poster presentation at ...

IBM has evolved the watsonx.data platform to address roadblocks in scaling generative and agent-based AI, especially the need ...

today announced that data on the long term efficacy and safety of its ALXN1840 (tiomolybdate choline) drug candidate for Wilson disease has been accepted for a late-breaker poster presentation at ...

Phase 1a dose-escalation study data update: treatment with NXP900 resulted in exposure ... of serious conditions of unmet medical need in oncology today provided poster presentation highlights for ...

How well data and research are integrated into a presentation or pitch can make or break it. But not every marketer is a natural-born data geek. How can you work staid data points into a compelling ...

announced today that new positive data on LX-101 against an increasingly wide variety of cancer types was selected for presentation at the 2025 American Association for Cancer Research (AACR ...

Showcase your company news with guaranteed exposure both in print and online The Future of Bay Area Biotech: Searching For Answers The Small Business Leaders awards program honors the dedicated ...